News tagged with research and development

Cancer drugs: better, cheaper

Cancer drug development is known to be too slow, costly and fraught with failure. Now the U.S. Food and Drug Administration is issuing recommendations for breast cancer trials that would substantially accelerate patient access ...

Jun 04, 2012
popularity not rated yet | comments 0

Valeant agrees to pay about $2.6B for Medicis

(AP)—Valeant Pharmaceuticals International Inc. has agreed to buy dermatology products maker Medicis Pharmaceutical Corp. for about $2.6 billion in cash in a deal to strengthen its position in skin treatments and care.

Sep 03, 2012
popularity not rated yet | comments 0